NVAX Jan 2025 5.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:22AM EDT. Market open.
| Previous close | 6.65 |
| Open | 6.65 |
| Bid | 8.65 |
| Ask | 9.15 |
| Strike | 5.50 |
| Expiry date | 2025-01-17 |
| Day's range | 6.65 - 6.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 307 |
ZacksBiotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
FX EmpireNovavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.
ZacksZacks Investment Ideas feature highlights: GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia
GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia have been highlighted in this Investment Ideas article.
© 2024 Yahoo. All rights reserved.